SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003737
Filing Date
2019-05-01
Accepted
2019-05-01 17:01:50
Documents
48
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20190331x10q.htm 10-Q 1158210
2 EX-31.1 mrns-20190331ex311a85bcf.htm EX-31.1 15194
3 EX-31.2 mrns-20190331ex312ba98e6.htm EX-31.2 15374
4 EX-32.1 mrns-20190331ex3219bfcce.htm EX-32.1 9424
5 GRAPHIC mrns20190331x10q001.jpg GRAPHIC 23678
6 GRAPHIC mrns20190331x10q002.jpg GRAPHIC 80088
  Complete submission text file 0001558370-19-003737.txt   3498694

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20190331.xml EX-101.INS 551839
8 EX-101.SCH mrns-20190331.xsd EX-101.SCH 20855
9 EX-101.CAL mrns-20190331_cal.xml EX-101.CAL 38101
10 EX-101.DEF mrns-20190331_def.xml EX-101.DEF 76504
11 EX-101.LAB mrns-20190331_lab.xml EX-101.LAB 244544
12 EX-101.PRE mrns-20190331_pre.xml EX-101.PRE 167942
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 19788458
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences